[HTML][HTML] Treatment of erectile dysfunction by intracavernosal administration of mesenchymal stem cells in patients with diabetes mellitus
Y Iskakov, R Omarbayev, R Nugumanov… - International braz j …, 2024 - SciELO Brasil
Erectile dysfunction is observed in about 50% of men. It has been found that diabetes
mellitus increases its prevalence to 19-86.3%, necessitating attention to a therapeutic …
mellitus increases its prevalence to 19-86.3%, necessitating attention to a therapeutic …
[HTML][HTML] Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
DB Pazzin, TTR Previato, JI Budelon Gonçalves… - Cells, 2024 - mdpi.com
This review delves into the groundbreaking impact of induced pluripotent stem cells (iPSCs)
and three-dimensional organoid models in propelling forward neuropathology research …
and three-dimensional organoid models in propelling forward neuropathology research …
Lineage‐Specific Mesenchymal Stromal Cells Derived from Human iPSCs Showed Distinct Patterns in Transcriptomic Profile and Extracellular Vesicle Production
T Winston, Y Song, H Shi, J Yang, M Alsudais… - Advanced …, 2024 - Wiley Online Library
Over the past decades, mesenchymal stromal cells (MSCs) have been extensively
investigated as a potential therapeutic cell source for the treatment of various disorders …
investigated as a potential therapeutic cell source for the treatment of various disorders …
[HTML][HTML] Comparison of the mesodermal differentiation potential between embryonic stem cells and scalable induced pluripotent stem cells
ET Tsai, HC Tseng, YH Liu, YR Wu… - Journal of the …, 2024 - journals.lww.com
Background: Mesenchymal stem cells (MSCs) have promising potential in clinical
application, whereas their limited amount and sources hinder their bioavailability. Embryonic …
application, whereas their limited amount and sources hinder their bioavailability. Embryonic …
iMSC: One leap closer to clinical applications
DM Hoang - Molecular Therapy-Methods & Clinical Development, 2023 - cell.com
Cerebral ischemia-reperfusion injury is a neurological injury arising from temporary
reduction or interruption of cerebral blood flow (ischemia) followed by subsequent …
reduction or interruption of cerebral blood flow (ischemia) followed by subsequent …
诱导多能干细胞来源的间充质干细胞的治疗潜力与应用风险.
赵陶然， 侯文怡， 王梦薇， 赵虹… - Chinese Journal of …, 2024 - search.ebscohost.com
摘要诱导多能干细胞衍生的间充质干细胞(iMSC) 已被提出作为原代间充质干细胞(MSC)
的替代来源, 在疾病治疗相关研究中也显示出多种优势. 但是iMSC 更适用于何种疾病类型 …
的替代来源, 在疾病治疗相关研究中也显示出多种优势. 但是iMSC 更适用于何种疾病类型 …
iPSCs and Organoids in Advancing Neuropathology Research and Therapies
DB Pazzin, T Previato, JIB Gonçalves, G Zanirati… - 2024 - preprints.org
This review explores the transformative role of induced pluripotent stem cells (iPSCs) and
organoids in advancing neuropathology research. Focused on Alzheimer's disease …
organoids in advancing neuropathology research. Focused on Alzheimer's disease …
[HTML][HTML] Unlocking the Potential: A Review of Stem Cell Applications in Regenerative Medicine
Z Musyarifah, R Rahmadian - Frontiers in …, 2024 - frontiersin-healthcare-research.org
Background: Regenerative medicine stands at the forefront of transformative healthcare,
offering innovative approaches to address tissue damage and degenerative conditions …
offering innovative approaches to address tissue damage and degenerative conditions …